share_log

AMD将向Absci战略投资2000万美元

AMD will make a strategic investment of 20 million dollars in Absci.

Breakings ·  Jan 8 20:31

On January 8, the generative AI drug research and development company Absci Corporation (NASDAQ: ABSI) announced a strategic collaboration with AMD to jointly deploy the AMD Instinct accelerator and ROCm Software to support critical AI new drug research and development workloads, including Absci's de novo antibody design model. AMD will also invest 20 million dollars in Absci in the form of a Private Equity investment (PIPE).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment